Bioscience Equity Partners (BEP) is a global investment bank, fund manager, and venture capital platform exclusively dedicated to the life-sciences sector. Headquartered across London, New York, Sydne
...
We are focused on discovery and development of immunotherapies to treat cancer, autoimmune and metabolic diseases. All pipeline is discovered inhouse and we look for out-license ex-China rights or glo
...
Lumigen Biotech is a Maryland-based oncology company developing NOVVA™, an antibody-guided nanocomplex platform designed to deliver high concentrations of chemotherapy into tumors that existing modali
...
Developing a diversified portfolio of precision ADCs (+Ph1 data) and small molecules (+Ph1b-2a data) targeting the tumor microenvironment (stroma) of highly invasive solid tumors, as well as other hig
...
ORF Biologics is a biotechnology company which is poised to provide customers with disruptive technologies to revolutionize the rapid synthesis and production of off the shelf and novel custom biologi
...
Pioneering Regenerative Macrophage Therapy in Inflammatory and Fibrotic Diseases.Clinical stage company with lead asset in Ph1/2 in end-stage liver disease, with clinical PoC in compensated cirrhosis.